Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
4743 | 1734 | 41.1 | 90% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
630 | 3 | HEPATIC ENCEPHALOPATHY//ASYMMETRIC DIMETHYLARGININE//HYPERAMMONEMIA | 13067 |
2078 | 2 | ASYMMETRIC DIMETHYLARGININE//ARGINASE//ADMA | 5239 |
4743 | 1 | ASYMMETRIC DIMETHYLARGININE//ADMA//DIMETHYLARGININE DIMETHYLAMINOHYDROLASE | 1734 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | ASYMMETRIC DIMETHYLARGININE | authKW | 5658576 | 28% | 66% | 488 |
2 | ADMA | authKW | 3382667 | 16% | 68% | 281 |
3 | DIMETHYLARGININE DIMETHYLAMINOHYDROLASE | authKW | 1679931 | 6% | 89% | 107 |
4 | SYMMETRIC DIMETHYLARGININE | authKW | 846173 | 3% | 83% | 58 |
5 | ASYMMETRIC DIMETHYLARGININE ADMA | authKW | 802363 | 3% | 76% | 60 |
6 | DIMETHYLARGININE | authKW | 686931 | 3% | 74% | 53 |
7 | DDAH | authKW | 636702 | 3% | 80% | 45 |
8 | ASYMMETRICAL DIMETHYLARGININE | authKW | 418436 | 2% | 61% | 39 |
9 | SDMA | authKW | 400539 | 3% | 39% | 59 |
10 | METHYLARGININES | authKW | 331767 | 2% | 61% | 31 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Peripheral Vascular Diseases | 5320 | 17% | 0% | 290 |
2 | Urology & Nephrology | 2655 | 12% | 0% | 208 |
3 | Cardiac & Cardiovascular System | 2094 | 15% | 0% | 254 |
4 | Medical Laboratory Technology | 997 | 4% | 0% | 73 |
5 | Endocrinology & Metabolism | 558 | 8% | 0% | 140 |
6 | Medicine, Research & Experimental | 454 | 7% | 0% | 124 |
7 | Pharmacology & Pharmacy | 295 | 10% | 0% | 176 |
8 | Transplantation | 215 | 3% | 0% | 47 |
9 | Biochemistry & Molecular Biology | 195 | 13% | 0% | 232 |
10 | Physiology | 190 | 5% | 0% | 80 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | NITR OXIDE SIGNALLING GRP | 90554 | 0% | 86% | 6 |
2 | UNIV VASC MED | 88762 | 1% | 46% | 11 |
3 | EXPT CLIN PHARMACOLCLIN PHARMACOL UNIT | 70432 | 0% | 100% | 4 |
4 | IDEXX BIOTECHNOL GRP | 52824 | 0% | 100% | 3 |
5 | TRANSLAT BIOMED SCI | 48144 | 1% | 11% | 26 |
6 | ARBEITSGRP KLIN PHARMAKOL | 46952 | 0% | 67% | 4 |
7 | BIOSYST REGULATCHIYODA KU | 46952 | 0% | 67% | 4 |
8 | HLTH PROMOT FAMILY CARE | 42252 | 0% | 40% | 6 |
9 | MED CELLULAR MOLEC SCI | 39617 | 0% | 75% | 3 |
10 | SCI MENTAL HLTH ADVERS UNIT | 39617 | 0% | 75% | 3 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | VASCULAR MEDICINE | 9440 | 1% | 3% | 21 |
2 | AMINO ACIDS | 7073 | 2% | 1% | 38 |
3 | ATHEROSCLEROSIS SUPPLEMENTS | 5132 | 1% | 3% | 9 |
4 | NITRIC OXIDE-BIOLOGY AND CHEMISTRY | 4637 | 1% | 1% | 19 |
5 | ATHEROSCLEROSIS | 2463 | 2% | 0% | 39 |
6 | VASCULAR PHARMACOLOGY | 1867 | 1% | 1% | 11 |
7 | ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY | 1803 | 2% | 0% | 28 |
8 | NEPHROLOGY DIALYSIS TRANSPLANTATION | 1592 | 2% | 0% | 34 |
9 | JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES | 1451 | 2% | 0% | 32 |
10 | INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES | 1415 | 2% | 0% | 28 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | ASYMMETRIC DIMETHYLARGININE | 5658576 | 28% | 66% | 488 | Search ASYMMETRIC+DIMETHYLARGININE | Search ASYMMETRIC+DIMETHYLARGININE |
2 | ADMA | 3382667 | 16% | 68% | 281 | Search ADMA | Search ADMA |
3 | DIMETHYLARGININE DIMETHYLAMINOHYDROLASE | 1679931 | 6% | 89% | 107 | Search DIMETHYLARGININE+DIMETHYLAMINOHYDROLASE | Search DIMETHYLARGININE+DIMETHYLAMINOHYDROLASE |
4 | SYMMETRIC DIMETHYLARGININE | 846173 | 3% | 83% | 58 | Search SYMMETRIC+DIMETHYLARGININE | Search SYMMETRIC+DIMETHYLARGININE |
5 | ASYMMETRIC DIMETHYLARGININE ADMA | 802363 | 3% | 76% | 60 | Search ASYMMETRIC+DIMETHYLARGININE+ADMA | Search ASYMMETRIC+DIMETHYLARGININE+ADMA |
6 | DIMETHYLARGININE | 686931 | 3% | 74% | 53 | Search DIMETHYLARGININE | Search DIMETHYLARGININE |
7 | DDAH | 636702 | 3% | 80% | 45 | Search DDAH | Search DDAH |
8 | ASYMMETRICAL DIMETHYLARGININE | 418436 | 2% | 61% | 39 | Search ASYMMETRICAL+DIMETHYLARGININE | Search ASYMMETRICAL+DIMETHYLARGININE |
9 | SDMA | 400539 | 3% | 39% | 59 | Search SDMA | Search SDMA |
10 | METHYLARGININES | 331767 | 2% | 61% | 31 | Search METHYLARGININES | Search METHYLARGININES |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | TOUSOULIS, D , GEORGAKIS, MK , OIKONOMOU, E , PAPAGEORGIOU, N , ZAROMITIDOU, M , LATSIOS, G , PAPAIOANNOU, S , SIASOS, G , (2015) ASYMMETRIC DIMETHYLARGININE: CLINICAL SIGNIFICANCE AND NOVEL THERAPEUTIC APPROACHES.CURRENT MEDICINAL CHEMISTRY. VOL. 22. ISSUE 24. P. 2871 -2901 | 217 | 63% | 1 |
2 | BOURAS, G , DEFTEREOS, S , TOUSOULIS, D , GIANNOPOULOS, G , CHATZIS, G , TSOUNIS, D , CLEMAN, MW , STEFANADIS, C , (2013) ASYMMETRIC DIMETHYLARGININE (ADMA): A PROMISING BIOMARKER FOR CARDIOVASCULAR DISEASE?.CURRENT TOPICS IN MEDICINAL CHEMISTRY. VOL. 13. ISSUE 2. P. 180-200 | 149 | 76% | 29 |
3 | CAPLIN, B , LEIPER, J , (2012) ENDOGENOUS NITRIC OXIDE SYNTHASE INHIBITORS IN THE BIOLOGY OF DISEASE MARKERS, MEDIATORS, AND REGULATORS?.ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY. VOL. 32. ISSUE 6. P. 1343 -+ | 128 | 77% | 37 |
4 | SCHWEDHELM, E , BOGER, RH , (2011) THE ROLE OF ASYMMETRIC AND SYMMETRIC DIMETHYLARGININES IN RENAL DISEASE.NATURE REVIEWS NEPHROLOGY. VOL. 7. ISSUE 5. P. 275-285 | 104 | 87% | 81 |
5 | BLACKWELL, S , (2010) THE BIOCHEMISTRY, MEASUREMENT AND CURRENT CLINICAL SIGNIFICANCE OF ASYMMETRIC DIMETHYLARGININE.ANNALS OF CLINICAL BIOCHEMISTRY. VOL. 47. ISSUE . P. 17-28 | 110 | 90% | 33 |
6 | PALM, F , ONOZATO, ML , LUO, ZM , WILCOX, CS , (2007) DIMETHYLARGININE DIMETHYLAMINOHYDROLASE (DDAH): EXPRESSION, REGULATION, AND FUNCTION IN THE CARDIOVASCULAR AND RENAL SYSTEMS.AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY. VOL. 293. ISSUE 6. P. H3227-H3245 | 131 | 62% | 145 |
7 | BELTOWSKI, J , KEDRA, A , (2006) ASYMMETRIC DIMETHYLARGININE (ADMA) AS A TARGET FOR PHARMACOTHERAPY.PHARMACOLOGICAL REPORTS. VOL. 58. ISSUE 2. P. 159-178 | 117 | 77% | 86 |
8 | CHEN, SF , LI, N , DEB-CHATTERJI, M , DONG, Q , KIELSTEIN, JT , WEISSENBORN, K , WORTHMANN, H , (2012) ASYMMETRIC DIMETHYARGININE AS MARKER AND MEDIATOR IN ISCHEMIC STROKE.INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. VOL. 13. ISSUE 12. P. 15983-16004 | 97 | 83% | 24 |
9 | LEIPER, J , NANDI, M , (2011) THE THERAPEUTIC POTENTIAL OF TARGETING ENDOGENOUS INHIBITORS OF NITRIC OXIDE SYNTHESIS.NATURE REVIEWS DRUG DISCOVERY. VOL. 10. ISSUE 4. P. 277 -291 | 118 | 63% | 66 |
10 | ARRIGONI, F , AHMETAJ, B , LEIPER, J , (2010) THE BIOLOGY AND THERAPEUTIC POTENTIAL OF THE DDAH/ADMA PATHWAY.CURRENT PHARMACEUTICAL DESIGN. VOL. 16. ISSUE 37. P. 4089 -4102 | 125 | 59% | 16 |
Classes with closest relation at Level 1 |